store

  • Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

    Human CMV (strain Merlin) IE1 199-207, ELKRKMIYM

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Immediate early protein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ELKRKMIYM-OH Specifications: 9mer peptide as TFA salt

  • Human CMV (UL28)

    Human CMV (UL28)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Uncharacterized protein Purity: >70% (HPLC-MS),…

  • Human CMV (UL36)

    Human CMV (UL36)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Uncharacterized protein Purity: >70% (HPLC-MS),…

  • Human CMV (UL48)

    Human CMV (UL48)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Deneddylase UL48 Purity: >70% (HPLC-MS),…

  • Human CMV (UL55)

    Human CMV (UL55)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Envelope protein Purity: >70% (HPLC-MS),…

  • Human CMV (UL82)

    Human CMV (UL82)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Phosphoprotein Purity: >70% (HPLC-MS), Development…

  • Human CMV (UL94)

    Human CMV (UL94)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Capsid-binding protein UL94 Purity: >70%…

  • Human CMV (US29)

    Human CMV (US29)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Uncharacterized protein Purity: >70% (HPLC-MS),…

  • Human CMV (US3)

    Human CMV (US3)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Glycoprotein Purity: >70% (HPLC-MS), Development…

  • Human CMV (US32)

    Human CMV (US32)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Cytomegalovirus disease, Infection, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in glass vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Uncharacterized protein Purity: >70% (HPLC-MS),…

  • Human CMV Envelope glycoprotein B  153-161, YAYIYTTYL

    Human CMV Envelope glycoprotein B 153-161, YAYIYTTYL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Envelope glycoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YAYIYTTYL-OH Specifications: 9mer peptide as TFA salt

  • Human CMV Envelope glycoprotein B  217-227, DYSNTHSTRYV

    Human CMV Envelope glycoprotein B 217-227, DYSNTHSTRYV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: Envelope glycoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-DYSNTHSTRYV-OH Specifications: 11mer peptide as TFA salt

  • Human CMV pp65 103-114, CPSQEPMSIYVY

    Human CMV pp65 103-114, CPSQEPMSIYVY

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-CPSQEPMSIYVY-OH Specifications: 12mer peptide as TFA salt

  • Human CMV pp65 115-128, ALPLKMLNIPSINVH

    Human CMV pp65 115-128, ALPLKMLNIPSINVH

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ALPLKMLNIPSINVH-OH Specifications: 15mer peptide as TFA salt

  • Human CMV pp65 116-129, LPLKMLNIPSINVH

    Human CMV pp65 116-129, LPLKMLNIPSINVH

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LPLKMLNIPSINVH-OH Specifications: 14mer peptide as TFA salt

  • Human CMV pp65 120-128, MLNIPSINV

    Human CMV pp65 120-128, MLNIPSINV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Infection Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-MLNIPSINV-OH Specifications: 9mer peptide as TFA salt